May 26, 2022

Dr. S Zalkind

Nucl Res Ctr Negev

POB 9001

IL-84190 Beer Sheva

ISRAEL

Dear Dr. Zalkind,

In view of your work in the field, your name has been recommended, as a potential reviewer, for the manuscript entitled “Potassium Iodide: give it timely, swiftly and judiciously” that has been submitted for publication in the journal Endocrine, Metabolic & Immune Disorders - Drug Targets. Please review the abstract below, to see if it comes in your direct field of expertise, and provide us a confirmation of your willingness to review the complete manuscript. I hope that you will be able to help us.

Title: Potassium Iodide: give it timely, swiftly and judiciously

Abstract: The International Atomic Energy Agency (IAEA) grades events in the nuclear industry (including in nuclear reactors transport storage and use of radioactive materials excluding military applications) on a 7-level scale [https//www.iaea.org/resources/databases/international-nuclear-and-radiological-event-scale]. In more than 50 years there have been only two level 7 nuclear accidents (NA): in Chernobyl (CNA) in 1986 and in Fukushima (FNA) in 2011. In both CNA and FNA among other radionuclides radioactive iodine isotopes were released in the environment ([125I] [131I] [132I] and [133I]) with [131I] being the most important due to its tissue-damaging beta radiation emission. In CNA approximately a total of 50x106 Ci of [131I] were released in the environment while in FNA 4x106 Ci of [131I] were discharged in the atmosphere [1-3]. The thyroid being an iodine-avid organ is particularly vulnerable in case of a nuclear accident. This vulnerability is age-delimited the most susceptible persons are the younger ones up to age 40.

I would appreciate it if you could kindly respond to this message at your earliest. Since we are endeavoring to provide an efficient review process for our authors, we would request that you send your comments and recommendations, if any, back to us as soon as possible.

In addition to carrying out this review, we would also like to propose your name, as a reviewer, to be included in the Reviewer Panel of this journals, and possibly others relevant to your field. Our Reviewer Portal will also offer its reviewers the following benefits and discounts on other Bentham services:

•         A free eBook of their Choice, on completion of two reviews

•         A 50% Fee Waiver on Quick Track rates on completion of 3 reviews

•         A 40% discount on Open Access Plus rates on completion of 4 reviews

As a member of our Reviewer panel, you would be expected to review a maximum of 3 articles every year. Please also note that to expedite the review, this request has been sent to several qualified researchers and once we get the first three commitments to review, we will not entertain any further acceptances.

Thank you for your consideration.

Regards,

Maryam Sharif

Editorial Manager